204 related articles for article (PubMed ID: 32879329)
1. The operational model of allosteric modulation of pharmacological agonism.
Jakubík J; Randáková A; Chetverikov N; El-Fakahany EE; Doležal V
Sci Rep; 2020 Sep; 10(1):14421. PubMed ID: 32879329
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Operational Models of Agonism and Allosterism at Receptors with Multiple Orthosteric Binding Sites.
Gregory KJ; Giraldo J; Diao J; Christopoulos A; Leach K
Mol Pharmacol; 2020 Jan; 97(1):35-45. PubMed ID: 31704718
[TBL] [Abstract][Full Text] [Related]
3. Allosteric modulation of family C G-protein-coupled receptors: from molecular insights to therapeutic perspectives.
Urwyler S
Pharmacol Rev; 2011 Mar; 63(1):59-126. PubMed ID: 21228259
[TBL] [Abstract][Full Text] [Related]
4. When simple agonism is not enough: emerging modalities of GPCR ligands.
Smith NJ; Bennett KA; Milligan G
Mol Cell Endocrinol; 2011 Jan; 331(2):241-7. PubMed ID: 20654693
[TBL] [Abstract][Full Text] [Related]
5. Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.
Jakubík J; Randáková A; El-Fakahany EE; Doležal V
PLoS One; 2019; 14(3):e0214255. PubMed ID: 30917186
[TBL] [Abstract][Full Text] [Related]
6. Allosteric modulation of G protein-coupled receptors: a pharmacological perspective.
Keov P; Sexton PM; Christopoulos A
Neuropharmacology; 2011 Jan; 60(1):24-35. PubMed ID: 20637785
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors.
Wootten D; Miller LJ
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():89-107. PubMed ID: 31454292
[TBL] [Abstract][Full Text] [Related]
8. A novel mechanism of G protein-coupled receptor functional selectivity. Muscarinic partial agonist McN-A-343 as a bitopic orthosteric/allosteric ligand.
Valant C; Gregory KJ; Hall NE; Scammells PJ; Lew MJ; Sexton PM; Christopoulos A
J Biol Chem; 2008 Oct; 283(43):29312-21. PubMed ID: 18723515
[TBL] [Abstract][Full Text] [Related]
9. Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery.
Sengmany K; Singh J; Stewart GD; Conn PJ; Christopoulos A; Gregory KJ
Neuropharmacology; 2017 Mar; 115():60-72. PubMed ID: 27392634
[TBL] [Abstract][Full Text] [Related]
10. Allosteric modulators of G-protein-coupled receptors.
May LT; Christopoulos A
Curr Opin Pharmacol; 2003 Oct; 3(5):551-6. PubMed ID: 14559102
[TBL] [Abstract][Full Text] [Related]
11. Unravelling intrinsic efficacy and ligand bias at G protein coupled receptors: A practical guide to assessing functional data.
Stott LA; Hall DA; Holliday ND
Biochem Pharmacol; 2016 Feb; 101():1-12. PubMed ID: 26478533
[TBL] [Abstract][Full Text] [Related]
12. Orthosteric/allosteric bitopic ligands: going hybrid at GPCRs.
Valant C; Sexton PM; Christopoulos A
Mol Interv; 2009 Jun; 9(3):125-35. PubMed ID: 19592673
[TBL] [Abstract][Full Text] [Related]
13. Estimation of ligand affinity constants for receptor states in functional studies involving the allosteric modulation of G protein-coupled receptors: implications for ligand bias.
Ehlert FJ; Griffin MT
J Pharmacol Toxicol Methods; 2014; 69(3):253-79. PubMed ID: 24434717
[TBL] [Abstract][Full Text] [Related]
14. Quantitative analysis of receptor allosterism and its implication for drug discovery.
Zhang R; Kavana M
Expert Opin Drug Discov; 2015 Jul; 10(7):763-80. PubMed ID: 25927503
[TBL] [Abstract][Full Text] [Related]
15. PAM-Antagonists: A Better Way to Block Pathological Receptor Signaling?
Kenakin T; Strachan RT
Trends Pharmacol Sci; 2018 Aug; 39(8):748-765. PubMed ID: 29885909
[TBL] [Abstract][Full Text] [Related]
16. Current Advances in Allosteric Modulation of Muscarinic Receptors.
Jakubik J; El-Fakahany EE
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32085536
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Drug Discovery and Development of Dualsteric/ Bitopic Activators of G Protein-Coupled Receptors.
Reinecke BA; Wang H; Zhang Y
Curr Top Med Chem; 2019; 19(26):2378-2392. PubMed ID: 31833462
[TBL] [Abstract][Full Text] [Related]
18. Mechanistic analysis of the function of agonists and allosteric modulators: reconciling two-state and operational models.
Roche D; Gil D; Giraldo J
Br J Pharmacol; 2013 Jul; 169(6):1189-202. PubMed ID: 23647200
[TBL] [Abstract][Full Text] [Related]
19. Allosteric agonists of 7TM receptors: expanding the pharmacological toolbox.
Langmead CJ; Christopoulos A
Trends Pharmacol Sci; 2006 Sep; 27(9):475-81. PubMed ID: 16889837
[TBL] [Abstract][Full Text] [Related]
20. Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2.
Doornbos MLJ; Vermond SC; Lavreysen H; Tresadern G; IJzerman AP; Heitman LH
Biochem Pharmacol; 2018 Sep; 155():356-365. PubMed ID: 30028996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
